Baker Tilly Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Baker Tilly Wealth Management, LLC

$377 Million
Q4 2025

A detailed history of Baker Tilly Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Baker Tilly Wealth Management, LLC holds 1,307 shares of REGN stock, worth $906,404. This represents 0.24% of its overall portfolio holdings.

Number of Shares

1,307

Previous 1,284 1.79%

Holding current value

$906,404

Previous $721,000 25.66%

% of portfolio

0.24%

Previous 0.17%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 08, 2026	BUY	$557.73 - $694.99 $12,827 - $15,984	23 Added 1.79%	1,307 $906,000
Q3 2025 Oct 09, 2025	BUY	$534.91 - $598.71 $2,139 - $2,394	4 Added 0.31%	1,284 $721,000
Q2 2025 Jul 10, 2025	BUY	$483.07 - $625.6 $60,383 - $78,200	125 Added 10.82%	1,280 $672,000
Q1 2025 Apr 09, 2025	BUY	$634.14 - $744.83 $406,483 - $477,436	641 Added 124.71%	1,155 $732,000
Q4 2024 Jan 10, 2025	SELL	$701.85 - $1046.91 $155,810 - $232,414	-222 Reduced 30.16%	514 $366,000

Q3 2024 Oct 24, 2024	BUY	$1024.09 - $1201.76 $140,300 - $164,641	137 Added 22.87%	736 $773,000
Q2 2024 Jul 18, 2024	SELL	$883.2 - $1071.19 $381,542 - $462,754	-432 Reduced 41.9%	599 $629,000
Q1 2024 May 09, 2024	BUY	$902.69 - $993.35 $2,708 - $2,980	3 Added 0.29%	1,031 $992,000
Q4 2023 Jan 10, 2024	SELL	$775.18 - $881.7 $188,368 - $214,253	-243 Reduced 19.12%	1,028 $902,000
Q3 2023 Oct 10, 2023	SELL	$692.45 - $844.37 $1.62 Million - $1.97 Million	-2,338 Reduced 64.78%	1,271 $1.05 Million
Q2 2023 Jul 20, 2023	BUY	$700.03 - $830.35 $53,902 - $63,936	77 Added 2.18%	3,609 $2.59 Million
Q1 2023 Apr 12, 2023	BUY	$680.49 - $826.97 $124,529 - $151,335	183 Added 5.46%	3,532 $2.9 Million
Q4 2022 Jan 26, 2023	SELL	$705.89 - $766.39 $59,294 - $64,376	-84 Reduced 2.45%	3,349 $0
Q3 2022 Oct 20, 2022	BUY	$573.97 - $724.32 $127,421 - $160,799	222 Added 6.91%	3,433 $2.37 Million
Q2 2022 Jul 28, 2022	SELL	$548.35 - $738.84 $239,628 - $322,873	-437 Reduced 11.98%	3,211 $1.9 Million
Q1 2022 Apr 27, 2022	BUY	$595.12 - $698.43 $319,579 - $375,056	537 Added 17.26%	3,648 $2.55 Million
Q4 2021 Feb 08, 2022	BUY	$543.48 - $670.97 $236,413 - $291,871	435 Added 16.26%	3,111 $1.97 Million
Q3 2021 Nov 02, 2021	BUY	$574.03 - $680.96 $316,864 - $375,889	552 Added 25.99%	2,676 $1.62 Million
Q2 2021 Jul 30, 2021	BUY	$472.8 - $558.54 $94,560 - $111,708	200 Added 10.4%	2,124 $1.19 Million
Q1 2021 Apr 28, 2021	SELL	$446.73 - $548.2 $92,919 - $114,025	-208 Reduced 9.76%	1,924 $910,000
Q4 2020 Feb 03, 2021	BUY	$478.3 - $607.98 $1.02 Million - $1.3 Million	2,132 New	2,132 $1.03 Million

Others Institutions Holding REGN

# of Institutions

1,501

Shares Held

86.6M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.

Account

Baker Tilly Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History